High-throughput approaches to discover novel immunomodulatory agents for cancer

Douglas W McMillin1, Constantine S Mitsiades

  • 1Department of Medical Oncology; Dana-Farber Cancer Institute; Boston, MA USA ; Department of Medicine; Harvard Medical School; Boston, MA USA.

Oncoimmunology
|December 18, 2012
PubMed

Related Concept Videos